Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles:
Related suggestion:
Youngkin vetoes bills on skill games, contraception and Confederate heritage tax breaks2 dead and 5 missing after a boat collision on the Danube River in HungaryCNN commentator and political adviser Alice Stewart dies at 58Champions LeagueHapoel Jerusalem win Israel's basketball State CupFrench security forces work to regain control of airport highway in violenceNeymar left off Brazil's squad for Copa AmericaHapoel Jerusalem win Israel's basketball State CupPremier League title race heading to the wireMbappe confirms PSG exit at end of season
2.519s , 6502.296875 kb
Copyright © 2024 Powered by J&J to pump another $13B into its MedTech business with Shockwave deal ,International Informer news portal